Relationships Between Sarcopenic Obesity and Insulin Resistance, Inflammation, and Vitamin D Status: the Korean Sarcopenic Obesity Study
Overview
Authors
Affiliations
Objective: It has been suggested that insulin resistance, low-grade inflammation and vitamin D deficiency are associated with obesity and sarcopenia. However, their relationships with sarcopenic obesity (SO) are unclear. We evaluated the impact of homoeostasis model assessment of insulin resistance (HOMA-IR), high-sensitivity C-reactive protein (hsCRP) and 25-hydroxyvitamin D (25[OH]D) levels on SO in Korean adults. STUDY SUBJECT/MEASUREMENTS: This study included 493 apparently healthy adults (180 men and 313 women) enrolled in the Korean Sarcopenic Obesity Study. Sarcopenia was defined as a skeletal muscle mass index (SMI) of 1 SD below the sex-specific mean value for a young reference group. Obesity was defined as a visceral fat area (VFA) ≥100 cm(2) . We classified the participants into four sarcopenia/obesity groups based on both SMI and VFA.
Results: The prevalence of SO was 17·8% in men and 24·9% in women. In women, the SO group had higher HOMA-IR and hsCRP levels compared with the non-SO group. In men, the 25[OH]D levels were significantly lower in the SO group than the non-SO group. Both hsCRP and HOMA-IR levels were negatively correlated with SMI and positively correlated with VFA in both men and women, whereas 25[OH]D levels were positively correlated with SMI in both men and women. Multiple binary logistic regression analysis showed that HOMA-IR and 25[OH]D levels were independently associated with SO in men, while HOMA-IR and hsCRP were significant factors predicting SO in women.
Conclusion: Insulin resistance, inflammation and vitamin D deficiency were associated with SO in a Korean adult population.
Wang X, Bai Y, Zhang F, Que H Eur J Med Res. 2025; 30(1):151.
PMID: 40033441 PMC: 11877682. DOI: 10.1186/s40001-025-02405-w.
Li Y, Guo W, Li H, Wang Y, Liu X, Kong W Biomolecules. 2025; 15(1).
PMID: 39858415 PMC: 11764331. DOI: 10.3390/biom15010020.
Xu C, He L, Tu Y, Guo C, Lai H, Liao C Front Public Health. 2024; 12:1472456.
PMID: 39624421 PMC: 11609067. DOI: 10.3389/fpubh.2024.1472456.
Liver Cirrhosis: The Immunocompromised State.
Rodriguez-Negrete E, Galvez-Martinez M, Sanchez-Reyes K, Fajardo-Felix C, Perez-Resendiz K, Madrigal-Santillan E J Clin Med. 2024; 13(18).
PMID: 39337069 PMC: 11432654. DOI: 10.3390/jcm13185582.
Jia X, Liu W, Ling X, Li J, Ji J, Wang B Heliyon. 2024; 10(17):e35888.
PMID: 39319151 PMC: 11419868. DOI: 10.1016/j.heliyon.2024.e35888.